DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Current Quarter	$-2.43	Next Quarter	$-1.22
Current Year	$-13.78	Next Year	$-6.38
QoQ Growth	+49.8%	YoY Growth	+53.7%
3Y EPS CAGR	-26.2%	Target Price	$16.00
Consensus	Buy	Upside	+34.6%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DRIO	$11.89	-6.82%	55.05K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DRIO	$11.89	-6.8%	55.05K
3
4
5
6

DRIO

DRIO

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get DarioHealth Corp. Data in Excel

Get DarioHealth Corp. Data in Excel